Search Results - Costantine Albany
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and D... by Costantine Albany, Mary J. Brames, Christopher A. Fausel, Cynthia S. Johnson, Joel Picus, Lawrence H. Einhorn
Published 2012Artigo -
3
-
4
-
5
Treatment of CD30-Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases by Costantine Albany, Lawrence H. Einhorn, Lawrence Garbo, Thomas E. Boyd, Neil C. Josephson, Darren R. Feldman
Published 2017Artigo -
6
Epigenetics in Prostate Cancer by Costantine Albany, Ajjai Alva, Ana M. Aparicio, Rakesh Singal, Sarvari V. Yellapragada, Guru Sonpavde, Noah M. Hahn
Published 2011Artigo -
7
-
8
Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014 by Nabil Adra, Sandra K. Althouse, H. Liu, Mary J. Brames, Nasser H. Hanna, Lawrence H. Einhorn, Costantine Albany
Published 2016Artigo -
9
Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206 by Nabil Adra, Lawrence H. Einhorn, Sandra K. Althouse, Natraj Reddy Ammakkanavar, Dana Musapatika, Costantine Albany, David J. Vaughn, Nasser H. Hanna
Published 2017Artigo -
10
Clinical Correlates of Benefit From Radium‐223 Therapy in Metastatic Castration Resistant Prostate Cancer by Ajjai Alva, Luke T. Nordquist, Stephanie Daignault, Saby George, Jorge Ramos, Costantine Albany, Sudhir Isharwal, Matthew McDonald, G. Douglas Campbell, Pongwut Danchaivijitr, Sarah Yentz, Aseem Anand, Evan Y. Yu
Published 2016Artigo -
11
Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors by Costantine Albany, Nabil Adra, Anna C. Snavely, Clint Cary, Timothy A. Masterson, Richard S. Foster, K. Kesler, Thomas M. Ulbright, Liang Cheng, Michal Chovanec, Fadi Taza, Kimberly Ku, Mary J. Brames, Nasser H. Hanna, Lawrence H. Einhorn
Published 2017Artigo -
12
Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine by Costantine Albany, Mary P. Hever-Jardine, Katherine M. von Herrmann, Christina Y. Yim, Janice Tam, Joshua M. Warzecha, Leah Shin, Sarah E. Bock, Brian S. Curran, Aneeq S. Chaudhry, Fred Kim, George E. Sandusky, Pietro Taverna, Sarah J. Freemantle, Brock C. Christensen, Lawrence H. Einhorn, Michael J. Spinella
Published 2016Artigo -
13
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options—An Analysis From the Global Germ Cell Cancer Group by Darren R. Feldman, Anja Lorch, Andrew Kramar, Costantine Albany, Lawrence H. Einhorn, Patrizia Giannatempo, Andrea Necchi, Aude Fléchon, Helen Boyle, Peter Chung, Robert Huddart, Carsten Bokemeyer, А. А. Tryakin, Teodoro Sava, Eric Winquist, Ugo De Giorgi, Jorge Aparicio, Christopher J. Sweeney, Gabriella Cohn Cedermark, J. Beyer, Thomas Powles
Published 2015Artigo -
14
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer by Christopher J. Sweeney, Ivor Percent, Sunil Babu, Jennifer L. Cultrera, Bryan A. Mehlhaff, Oscar B. Goodman, David Morris, Ian D. Schnadig, Costantine Albany, Neal D. Shore, Paul Sieber, Susan C. Guba, Yaoguang Zhang, Volker Wacheck, Gregory P. Donoho, Anna M. Szpurka, Sophie Callies, Boris K. Lin, Johanna C. Bendell
Published 2022Artigo -
15
Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm by Torgrim Tandstad, Christian Kollmannsberger, Bruce J. Roth, Claudio Jeldres, Silke Gillessen, Karim Fizazi, Siamak Daneshmand, William T. Lowrance, Nasser H. Hanna, Costantine Albany, Richard S. Foster, Gabriella Cohn Cedermark, Darren R. Feldman, Thomas Powles, Mark A. Lewis, Peter Grimison, Douglas Bank, Christopher R. Porter, Peter Albers, Maria De Santis, Sandy Srinivas, George J. Bosl, Craig R. Nichols
Published 2017Artigo -
16
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastat... by Emmanuel S. Antonarakis, Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla V. Ballman, Marie Vanhuyse, Guru Sonpavde, Scott North, Costantine Albany, Che‐Kai Tsao, John A. Stewart, Atef Zaher, Ted P. Szatrowski, Wei Zhou, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Timothy B. Lannin, Shalu Suri, Conor Gruber, Erica D. Pratt, Brian J. Kirby, Mario A. Eisenberger, David M. Nanus, Fred Saad, Paraskevi Giannakakou
Published 2017Artigo -
17
Differential Activity of PARP Inhibitors in <i>BRCA1</i>- Versus <i>BRCA2</i>-Altered Metastatic Castration-Resistant Prostate Cancer by Fadi Taza, Albert Holler, Wei Fu, Hao Wang, Nabil Adra, Costantine Albany, Ryan Ashkar, Heather H. Cheng, Alexandra Sokolova, Neeraj Agarwal, Adam Kessel, Alan H. Bryce, Nellie Nafissi, Pedro C. Barata, Oliver Sartor, Diogo Assed Bastos, Òren Smaletz, Jacob E. Berchuck, Mary‐Ellen Taplin, Rahul Aggarwal, Cora N. Sternberg, Panagiotis J. Vlachostergios, Ajjai Alva, Christopher T. Su, Catherine H. Marshall, Emmanuel S. Antonarakis
Published 2021Artigo -
18
Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012 by Maha Hussain, Stephanie Daignault−Newton, Przemyslaw Twardowski, Costantine Albany, Mark N. Stein, Lakshmi P. Kunju, Javed Siddiqui, Yi-Mi Wu, Dan R. Robinson, Robert J. Lonigro, Xuhong Cao, Scott A. Tomlins, Rohit Mehra, Kathleen A. Cooney, Bruce Montgomery, Emmanuel S. Antonarakis, Daniel H. Shevrin, Paul G. Corn, Young E. Whang, David C. Smith, Megan E.V. Caram, Karen E. Knudsen, Walter M. Stadler, Felix Y. Feng, Arul M. Chinnaiyan
Published 2017Artigo -
19
A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with <i>FGFR3</i> Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157 by Noah M. Hahn, Trinity J. Bivalacqua, Ashley E. Ross, George J. Netto, Alex S. Baras, Jong‐Chul Park, Carolyn G. Chapman, Timothy A. Masterson, Michael O. Koch, Richard Bihrle, Richard S. Foster, Thomas A. Gardner, Liang Cheng, David Jones, Kyle McElyea, George E. Sandusky, T. Breen, Ziyue Liu, Costantine Albany, Marietta L. Moore, Rhoda L. Loman, Angela Reed, Scott A. Turner, Francine B. de Abreu, Torrey M. Gallagher, Gregory J. Tsongalis, Elizabeth R. Plimack, Richard E. Greenberg, Daniel M. Geynisman
Published 2016Artigo -
20
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium by Silke Gillessen, Nicolas Sauvé, Laurence Collette, Gedske Daugaard, Ronald de Wit, Costantine Albany, А. А. Tryakin, Karim Fizazi, Olof Ståhl, Jourik A. Gietema, Ugo De Giorgi, Fay Cafferty, Aaron R. Hansen, Torgrim Tandstad, Robert Huddart, Andrea Necchi, Christopher J. Sweeney, Xavier García del Muro, Daniel Yick Chin Heng, Anja Lorch, Michal Chovanec, Eric Winquist, Peter Grimison, Darren R. Feldman, Angelika Terbuch, Marcus Hentrich, Carsten Bokemeyer, Helene F. S. Negaard, Christian D. Fankhauser, Jonathan Shamash, David J. Vaughn, Cora N. Sternberg, Axel Heidenreich, J. Beyer
Published 2021Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Oncology
Cancer
Chemotherapy
Germ cell tumors
Prostate cancer
Urology
Androgen receptor
Biochemistry
Biology
Cancer research
Cisplatin
Clinical trial
Etoposide
Gastroenterology
Gene
Pathology
Testicular cancer
Antiemetic
Chemistry
Chemotherapy-induced nausea and vomiting
Clinical endpoint
Enzalutamide
Genetics
Metastasis
Nausea
Progression-free survival
Surgery
Vomiting